2gjz
(L)
|
Catalytic elimination antibody 13G5 light cha
|
217
|
2.65
|
3
|
0.98v1 + 0.45v2
|
2gk0
(L)
|
Catalytic elimination antibody 13G5 light cha
|
217
|
2.45
|
4
|
1.0v1 + 0.99v2
|
1cl7
(L)
|
PROTEIN (IGG1 ANTIBODY 1696 (light chain))
|
216
|
3
|
2
|
0.97v1 + 0.17v2
|
1f3d
(J)
|
CATALYTIC ANTIBODY 4B2
|
218
|
1.87
|
2
|
0.99v1 + 0.27v2
|
2dqt
(L)
|
IMMUNOGLOBULIN 6D9
|
219
|
1.8
|
2
|
0.97v1 + 0.07v2
|
2gjz
(A)
|
Catalytic elimination antibody 13G5 light cha
|
217
|
2.65
|
2
|
0.98v1 + 0.12v2
|
1bln
(C)
|
PROTEIN (MONOCLONAL ANTIBODY MRK-16 (LIGHT CH
|
214
|
2.8
|
3
|
0.98v1 + 0.81v2
|
2pcp
(C)
|
IMMUNOGLOBULIN
|
216
|
2.2
|
3
|
0.98v1 + 0.83v2
|
1fl6
(A)
|
ANTIBODY GERMLINE PRECURSOR TO 28B4
|
217
|
2.8
|
3
|
0.99v1 + 0.83v2
|
1fl6
(L)
|
ANTIBODY GERMLINE PRECURSOR TO 28B4
|
217
|
2.8
|
3
|
0.99v1 + 0.83v2
|
1igf
(M)
|
IGG1-KAPPA B13I2 FAB (LIGHT CHAIN)
|
219
|
2.8
|
3
|
0.99v1 + 0.53v2
|
2jel
(L)
|
JEL42 FAB FRAGMENT
|
217
|
2.5
|
3
|
0.97v1 + 0.58v2
|
1i9j
(L)
|
RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB
|
219
|
2.6
|
3
|
1.0v1 + 0.72v2
|
1i9i
(L)
|
RECOMBINANT MONOCLONAL ANTI-TESTOSTERONE FAB
|
219
|
2.72
|
3
|
1.0v1 + 0.74v2
|
1lo4
(L)
|
If kappa light chain
|
217
|
2.4
|
3
|
1.01v1 + 0.71v2
|
1cly
(L)
|
IGG FAB (HUMAN IGG1, KAPPA)
|
217
|
2.5
|
3
|
1.0v1 + 0.73v2
|
2pcp
(A)
|
IMMUNOGLOBULIN
|
216
|
2.2
|
3
|
1.0v1 + 0.74v2
|
1bln
(A)
|
PROTEIN (MONOCLONAL ANTIBODY MRK-16 (LIGHT CH
|
214
|
2.8
|
3
|
0.99v1 + 0.71v2
|
1qfu
(L)
|
PROTEIN (IMMUNOGLOBULIN IGG1-KAPPA ANTIBODY (
|
217
|
2.8
|
3
|
0.98v1 + 0.7v2
|
1ucb
(L)
|
CHIMERIC HUMAN/MOUSE IGG FAB FRAGMENT BR96
|
216
|
2.5
|
3
|
1.0v1 + 0.7v2
|
2g60
(L)
|
anti-FLAG M2 Fab light chain
|
213
|
1.85
|
3
|
1.02v1 + 0.84v2
|
2gk0
(A)
|
Catalytic elimination antibody 13G5 light cha
|
217
|
2.45
|
4
|
1.0v1 + 1.0v2
|
1plg
(L)
|
IGG2A=KAPPA=
|
215
|
2.8
|
2
|
1.0v1
|